The U.S. Preventive Services Task Force (USPSTF) recommends against screening asymptomatic adults for chronic obstructive pulmonary disease (COPD). This recommendation forms the basis of a final recommendation statement published ...
May 10, 2022
0
7
The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released a new guideline for the management of Kawasaki disease that addresses diagnostic issues relating to Kawasaki disease, ...
Mar 08, 2022
0
8
A University of Pennsylvania study published today in Nature Communications offers striking evidence that network science can be used to remove race and gender bias in clinical settings. The study, led by Professor Damon ...
Nov 15, 2021
0
6
Researchers at City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, have developed a tool that could predict if older adults with early-stage breast ...
Jan 15, 2021
0
0
Physicians who follow artificial intelligence (AI) advice may be considered less liable for medical malpractice than is commonly thought, according to a new study of potential jury candidates in the U.S. Published in the ...
Jan 12, 2021
0
7
The anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has "no important effect" on survival chances, the World Health Organization said Friday.
Nov 20, 2020
0
8
The American College of Rheumatology (ACR) will preview its 2020 Guideline for the Management of Rheumatoid Arthritis (RA) at ACR Convergence, the ACR's annual meeting. The comprehensive, clinical recommendations for pharmacologic ...
Nov 06, 2020
0
2
The success of an Australian program which aims to find the most-likely-to-succeed personalized treatment recommendations for children with high risk cancer has been revealed in a paper published today 6 October in the prestigious ...
Oct 05, 2020
0
48
Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart ...
Aug 31, 2020
0
4
In The BMJ today, a panel of international experts make a weak recommendation for the use of remdesivir in patients with severe covid-19, and strongly support continued enrolment of patients into ongoing clinical trials of ...
Jul 31, 2020
0
3
